COVID-19 can cause a clinical spectrum from asymptomatic disease to life-threatening respiratory failure and acute respiratory distress syndrome (ARDS). There is an ongoing discussion whether the clinical presentation and ventilatory parameters are the same as typical ARDS or not. There is no clear understanding of how the hemodynamic parameters have been affected in COVID-19 ARDS patients. We aimed to compare hemodynamic and respiratory parameters of moderate and severe COVID-19 and non-COVID-19 ARDS patients. These patients were monitored with an advanced hemodynamic measurement system by the transpulmonary thermodilution method in prone and supine positions. Data of 17 patients diagnosed with COVID-19 and 16 patients diagnosed with other types of diseases with moderate and severe ARDS, mechanically ventilated, placed in a prone position, had advanced hemodynamic measurements with PiCCO, and stayed in the intensive care unit for more than a week were analyzed retrospectively. Patient characteristics and arterial blood gases analysis recorded at admission and respiratory and advanced hemodynamic parameters during the first week were compared in prone and supine positions. No difference was observed in the respiratory parameters including respiratory system compliance between COVID-19 and non-COVD-19 patients in prone and supine positions. In comparison of advanced hemodynamic parameters in the first week of intensive care, the extravascular lung water and pulmonary vascular permeability indexes measured in supine position of COVID-19 ARDS patients were found to be significantly higher than non-COVID-19 patients. Duration of prone position was significantly longer in patients diagnosed with COVID-19 ARDS. The results of this study suggested that COVID-19 ARDS is a variant of typical ARDS with a different pathophysiology. Asar S, Acicbe Ö, Sabaz MS, Tontu F, Canan E, Cukurova Z, et al. Comparison of Respiratory and Hemodynamic Parameters of COVID-19 and Non-COVID-19 ARDS Patients. Indian J Crit Care Med 2021;25(6):704–708.
Methanol, a toxic substance, has been identified as a causative agent for lethal poisoning. The present case series includes nine patients admitted to the intensive care unit (ICU) due to methanol poisoning between 25th November 2024 and 13th January 2025. The median age of the patients was 49 (43-54) years, with eight of them being male. All patients exhibited high anion gap metabolic acidosis and underwent renal replacement therapy. The majority of the patients received a combination of ethanol and folinic acid therapies. It is noteworthy that a third of patients experienced a cardiopulmonary arrest either in their own homes or in the immediate period following their admission to the hospital. Six patients survived to ICU discharge: four were transferred to hospital wards or discharged from the hospital, and two were transferred to palliative care units. One patient died shortly after ICU admission, another died during prolonged ICU follow-up, and one was diagnosed with brain death and subsequently underwent organ procurement surgery. In conclusion, a deteriorated neurological state, receipt of cardiopulmonary resuscitation, and the presence of pathological findings in radiological imaging of the central nervous system, cardiac injury, vasopressor requirement, sepsis, and ventilator-associated pneumonia were likely to be associated with an increased risk of poor outcomes.